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A recently published paper in Oncogene, led by Avivar-Valderas and colleagues, illustrates the finding of a heretofore-unknown regulatory pathway governing ECM detachment and autophagic activation within mammary epithelial cells (MECs) . Utilizing MCF10A cells, the authors uncovered that PERK is required and promotes autophagy via LKB1/ AMPK/TSC2 activation. Moreover, PERK mediated inhibition of mTORC1 (and ensuing autophagy) is independent of canonical ER stress signals (Fig. 1) . In essence, PERK competently and rapidly relays proautophagic signals that solely originate from the loss of ECM adhesion. Conversely, re-engagement of ECM suppresses this novel form of context-specific PERK signaling, thereby terminating pro-autophagic responses. Collectively, these findings stipulate a quickly facilitated response from PERK for the concerted activation of AMPK and TSC2 and mTORC1 inhibition for suspension-induced MEC autophagy. Aberrant and sustained activation of this pathway may promote early carcinoma formation.
Reaping sugars: eukaryotic OST is responsible for generating free oligosaccharides
Harada, Y., Buser, R., Ngwa, E.M., Hirayama, H., Aebi, M., Suzuki, T., 2013. Eukaryotic oligosaccharyltransferase generates free oligosaccharides during N-glycosylation. J. Biol. Chem. 288, 32673-32684. http:// www.ncbi.nlm.nih.gov/pubmed/24062310.
In a recent study by Harada et al. and published in The Journal of Biological Chemistry, the enzyme primarily responsible for releasing the unbound oligosaccharide was identified and characterized. The free oligosaccharides (fOS), which are structurally reminiscent of N-glycan, are liberated into the ER lumen by the multi-protein and membrane bound complex, oligosaccharyltransferase (OST). OST hydrolytically cleaves donor substrates composed of dolichylpyrophophoryl oligosaccharides (DLOs) for fOS formation. While N-glycosylation is mediated by OST, genetic and biochemical approaches revealed that fOS generation and N-glycosylation activities are stringently regulated for viable efficiency and fidelity. Importantly, utilizing purified subunits, the authors determined that the catalytic capacity for fOS generation resides within Stt3. Intriguingly; Stt3 contains the activity for both Nglycosylation as well as for fOS generation. However, mutagenesis hints that seemingly disparate regions within Stt3 orchestrate these opposing functions and balance N-glycosylation and fOS formation. The study provides evidence that fOS generation via OST is not influenced by the concentration of DLOs nor is OST required to bind acceptor peptides for fOS liberation. Indeed, OST possesses an intrinsic ability for fOS release directly from DLOs (Fig. 2) .
Clogging the vessels: αvβ3 and fibronectin promotes clot invasion and metastasis
Knowles, L.M., Gurski, L.A., Engel, C., Gnarra, J.R., Maranchie, J.K., Pilch, J., 2013. Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis. Cancer Res. 73, 6175-6184. http://www.ncbi.nlm.nih.gov/pubmed/23966293.
A recent study published in Cancer Research by Knowles and colleagues found that fibronectin and activated integrin αvβ3 induces expression of Slug, a master transcriptional regulator involved in orchestrating tumor cell invasion and metastasis. Indeed, the process of clot formation establishes a tumor niche conducive for maintaining and advocating the growth and proliferation of tumor initiating cells. This process is particularly important for lung colonization, as exemplified by renal cell carcinomas and soft tissue sarcomas. Mechanistically, a fibronectin matrix is deposited and fashioned downstream from activated integrin αvβ3 following interactions with the provisional matrix provided by the clotted plasma components (Fig. 3A,B) . Enhanced invadopodia formation result from integrin αvβ3 signaling for the (Fig. 3C) . Thus, the authors have developed a scheme whereby a trifecta of integrin αvβ3 signaling, fibronectin, and increased Slug expression begin defining the lungcentric invasion and metastatic proclivity of certain malignancies. In a recent study by Witt and colleagues and published in The Journal of Biological Chemistry, for the first time, defined the physiochemical identities of heparan sulfate proteoglycans (HSPGs) that function as co-receptors for Sonic Hedgehog (Shh) signaling in neural precursor cells. As such, the authors have discovered that HSPGs that contain a glypican 5 core protein function as co-receptors. Importantly, HS chains attached to the glypican 5 core must strictly contain a 2-O-sulfo- Fig. 1 . ECM-detached MECs initiate rapid PERK orchestrated signaling events that activate the pro-autophagic LKB1/AMPK/TSC2 pathway for mTORC1 inhibition. We thank AvivarValderas, A. for kindly providing this figure. Fig. 2 . OST is responsible for generation free oligosaccharides into the ER lumen via direct cleavage of dolichol-linked oligosaccharides. We kindly thank Harada, Y. for the figure. iduronic acid modification residing at the non-reducing end of the chain (Fig. 4) . Therefore, these two parameters allow the HSPG as a functional Shhbinding co-receptor. Functionally, RNAi-mediated silencing of these components significantly attenuated Shh-dependent responses. Further, the study investigated the sub-cellular distribution of glypican 5 and found localization with the primary cilia, the hub of Shh signal transduction (Fig. 4) . Biologically, HSPG's containing a glypican 5 core and the 2-O-sulfoiduronic acid are appropriately located and function at both the tissue and cellular level for neural cell precursor proliferation.
Severe microenvironments account for the distribution of tumorassociated Macrophages
Carmona-Fontaine, C., Bucci, V., Akkari, L., Deforet, M., Joyce, J.A., Xavier, J.B., 2013. Emergence of spatial structure in the tumor microenvironment due to the Warburg effect. Proc. Natl. Acad. Sci. USA 110, 19402-19407 . http://www.ncbi.nlm.nih.gov/pubmed/24218566.
A recent report published in PNAS by Carmona-Fontaine and colleagues provides one explanation for the variable pattern of tumorassociated macrophages (TAMs) observed in vivo. The authors combine in vitro co-culture experiments alongside mathematical models to define TAM lactic acid sensitivity as a crucial element of pattern determination. These results suggest tumor microenvironments high in lactic acid would provide unfavorable conditions for macrophage survival. Such environments would prevent homogeneous macrophage accumulation throughout the tumor (Fig. 5 ). Together these results highlight metabolic gradients as a means to coordinate stromal cell distribution within the tumor microenvironment. A recent report published in Nature Medicine by Henderson and colleagues clarifies the role of αv integrin during organ fibrosis. The authors were able to delete αv integrin from the myofibroblasts in vivo. The absence of αv integrin conferred protection against fibrosis induced in the liver, kidney and lung. Global deletion of integrins β3, β5, β6 or conditional deletion of integrin β8 was not able to phenocopy a Fig. 3 . Integrin αvβ3 binding to clotted plasma promotes renal cell carcinoma and soft tissue sarcoma metastasis to the lung. Please refer to the above Highlight for a detailed description. We thank Knowles, L.M. for kindly providing the figure. Fig. 4 . HSPGs with a glypican 5 core and 2-O-sulfo iduronate act as a Shh co-receptor and promote the proliferation of neural cell precursors. The graphic is a rendered cell surface, with a primary cilium (green); flanking the cilium are glypicans (red) with attached glycosaminoglycan chains (white) modified with 2-O-sulfo iduronate at the non-reducing end (blue) and Ptch receptors (yellow). Actual images of neural precursors (blue), with proteoglycan staining (red) adjacent to the primary cilia (green) comprises the superimposed background. We thank Witt, R.M. for kindly providing the figure. similar protection. These results suggest αv heterodimerizes with either β1 or multiple β-integrins to control fibrosis. The lack of αv prevented the activation of TGF-β. Furthermore, small molecule targeted inhibition of αv (CWHM 12) was able to prevent the onset or progression of fibrosis in vivo. These results identify αv integrin as a druggable target for fibrotic diseases across multiple organ types. 
